Inflammatory aortitis in a patient with aggressive B-cell lymphoma during treatment within the NIVEAU trial: Gradual re-exposition with Nivolumab, Rituximab, Gemcitabine and Oxaliplatin identifies G-CSF as the provoking agent

Meedt, E. and Held, G. and Poeschel, V. and Loher, A. and Luerken, L. and Menhart, K. and Hellwig, D. and Grube, M. and Herr, W. and Mayer, S. (2020) Inflammatory aortitis in a patient with aggressive B-cell lymphoma during treatment within the NIVEAU trial: Gradual re-exposition with Nivolumab, Rituximab, Gemcitabine and Oxaliplatin identifies G-CSF as the provoking agent. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020, Virtuell.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Lehrstuhl für Röntgendiagnostik
Medicine > Abteilung für Nuklearmedizin
Depositing User: Petra Gürster
Date Deposited: 20 Apr 2021 05:53
Last Modified: 20 Apr 2021 05:53
URI: https://pred.uni-regensburg.de/id/eprint/43692

Actions (login required)

View Item View Item